Evidence map›Paper›PMID 24024891›Full record

ArticlePharmacogenomics2013

Institutional Profile: University of Chicago Center for Personalized Therapeutics: research, education and implementation science.

M Eileen Dolan, Michael L Maitland, Peter H O'Donnell, Yusuke Nakamura, Nancy J Cox, Mark J Ratain

Abstract read
In one paragraph

Article in Pharmacogenomics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

M Eileen DolanCommittee on Clinical Pharmacology & Pharmacogenomics, 900 E 57th Street, KCBD 7100, University of Chicago, Chicago, IL 60637, USA.
Michael L Maitland
Peter H O'Donnell
Yusuke Nakamura
Nancy J Cox
Mark J Ratain

Funding

Whole GenomeU01GM061393 · NIGMS · UNIVERSITY OF CHICAGO · PI DOLAN, MARY EILEEN · 2000 to 2014
$39.0M
Developing an Oncology Workforce for the 21st Century - Renewal 01K12CA139160 · NCI · UNIVERSITY OF CHICAGO · PI OLOPADE, OLUFUNMILAYO F., SMITH, SONALI · 2010 to 2024
$10.6M
CLINICAL THERAPEUTICST32GM007019 · NIGMS · UNIVERSITY OF CHICAGO · PI Peter Hugh O'Donnell, MARK J RATAIN · 1985 to 2026
$8.7M
The 1200 Patients Project: Studying Clinical Implementation of PharmacogenomicsK23GM100288 · NIGMS · UNIVERSITY OF CHICAGO · PI O'DONNELL, PETER HUGH · 2013 to 2016
$751k
NCI NIH HHS K12 CA139160NIGMS NIH HHS K23 GM100288NIGMS NIH HHS T32 GM007019NIGMS NIH HHS U01 GM061393
6 · The paper itself

Abstract

Pharmacogenomics is aimed at advancing our knowledge of the genetic basis of variable drug response. The Center for Personalized Therapeutics within the University of Chicago comprises basic, translational and clinical research as well as education including undergraduate, graduate, medical students, clinical/postdoctoral fellows and faculty. The Committee on Clinical Pharmacology and Pharmacogenomics is the educational arm of the Center aimed at training clinical and postdoctoral fellows in translational pharmacology and pharmacogenomics. Research runs the gamut from basic discovery and functional studies to pharmacogenomic implementation studies to evaluate physician adoption of genetic medicine. The mission of the Center is to facilitate research, education and implementation of pharmacogenomics to realize the true potential of personalized medicine and improve the lives of patients.

Indexed as

UniversitiesBiomedical ResearchChicagoHumansPharmacogeneticsPhysiciansPrecision MedicineStudents

Identifiers

PMID24024891
PMCPMC4022693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.